HI
IMGN

HBK Investments’s Immunogen Inc IMGN Stock Holding History

HBK Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-59,531
Closed -$161K – 1113
2019
Q1 		$161K Buy
+59,531
New +$258K ﹤0.01% 990
2016
Q1 		– Sell
-57,500
Closed -$780K – 1154
2015
Q4 		$780K Buy
57,500
+9,600
+20% +$118K 0.01% 632
2015
Q3 		$460K Buy
+47,900
New +$700K ﹤0.01% 770

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HBK Investments's IMGN Position: Q2 2019 in Review

HBK Investments sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 59,531 shares — an estimated $161K sold.

HBK Investments first reported a position in IMGN in Q3 2015 and held it in 3 quarters. The position peaked at $780K in Q4 2015. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • HBK Investments reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 59,531 Immunogen Inc shares in Q2 2019, an estimated $161K.
  • HBK Investments first reported a position in Immunogen Inc in Q3 2015 and held it in 3 quarters.
  • HBK Investments's Immunogen Inc position peaked at $780K in Q4 2015.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.